ABD 320
Alternative Names: ABD-320Latest Information Update: 03 Feb 2025
Price :
$50 *
At a glance
- Originator Abdera Therapeutics
- Class Antibodies; Antineoplastics; Immunoconjugates; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours